ライフサイエンスコーパス: ribosomal protein S6

1 RvE1 also stimulated the phosphorylation of ribosomal protein S6.

2 with reduced tumor levels of phosphorylated ribosomal protein S6.

3 hinery, including S6k1 and its substrate the ribosomal protein S6.

4 EPRS, but not canonical S6K1 targets, e.g., ribosomal protein S6.

5 ty and its downstream effectors GSK3beta and ribosomal protein S6.

6 2 of 22 (100%) p-p70S6K, and 5 of 20 (25%) p-ribosomal protein S6.

7 in phosphorylation of the p70S6K substrate, ribosomal protein S6.

8 of the translation factors eIF4E, 4EBP1, and ribosomal protein S6.

9 ng p70 S6 kinase and, consequently, the 40 S ribosomal protein S6.

10 structural gatekeepers on the folding of the ribosomal protein S6.

11 G, eIF4E, 4E-binding protein 1 (4E-BP1), and ribosomal protein S6.

12 tration resulted in the dephosphorylation of ribosomal protein S6.

13 tion: eukaryotic initiation factor eIF4E and ribosomal protein S6.

14 y virtue of its ability to phosphorylate the ribosomal protein S6.

15 esponsible for its enzymatic activity toward ribosomal protein S6.

16 e sdgH class affects rpsF, which encodes the ribosomal protein S6.

17 irus results in increased phosphorylation of ribosomal protein S6.

18 m response factor, c-Fos, Nur77, and the 40S ribosomal protein S6.

19 of V-ATPase represses the phosphorylation of ribosomal protein S6.

20 neurons, and higher amount of phosphorylated ribosomal protein S6.

21 mA, CcmB, CcmC, and CcmF) alongside a unique ribosomal protein S6.

22 by phosphorylation of the downstream target, ribosomal protein S6.

23 ated with increased levels of phosphorylated ribosomal protein S6.

24 ORC1, as reflected by phosphorylation of the ribosomal protein S6.

25 es, and decreased phosphorylation of AKT and ribosomal protein S6.

26 of protein synthesis by phosphorylating the ribosomal protein, S6.

27 lso abrogated the phosphorylation of p70S6K, ribosomal protein S6, 4E-BP1, and eIF4E induced by PDGF-

28 d its downstream effector molecules, p70S6K, ribosomal protein S6, 4E-BP1, and eIF4E.

29 activity and phosphorylation of Akt, p70S6K, ribosomal protein S6, 4E-BP1, and eIF4E.

30 nstrate that both S18 proteins interact with ribosomal protein S6, a committed step in ribosome bioge

31 ultimately regulates the phosphorylation of ribosomal protein S6, a critical step in the insulin sig

32 culocytes show high levels of phosphorylated ribosomal protein S6, a downstream target of mTORC1.

33 Here, we show that ribosomal protein S6, a structural component of the ribo

34 40 S ribosomal protein S6, a target of p70(S6K), and 4E-BP1,

35 The 30-kDa protein was identified as ribosomal protein S6, a translational regulator, and its

36 uced Akt, mammalian target of rapamycin, and ribosomal protein S6 activation was significantly attenu

37 -LTD, through a mechanism involving mTOR and ribosomal protein S6 activation.

38 targets of mTORC1, S6 kinase 1 (S6K1) and S6 ribosomal protein (S6), after administration of the FAS

39 crease in immunoreactivity of phosphorylated ribosomal protein S6, an AKT pathway downstream target.

40 lation of BHD reduces the phosphorylation of ribosomal protein S6, an indicator of TORC1 activity.

41 clone displayed prolonged phosphorylation of ribosomal protein S6, an integrator of MAPK and AKT acti

42 , we found that the translational regulators ribosomal protein S6 and 4E-BP1 are constitutively phosp

43 ects of MTI on proliferation, apoptosis, and ribosomal protein S6 and 4E-BP1 phosphorylation in cell

44 M(-/-) splenic CD8(+) T cells have increased ribosomal protein S6 and Akt phosphorylation and do not

45 Ribosomal protein S6 and an S6 kinase are phosphorylated

46 S6K, and 4E-BP1 and their effector molecules ribosomal protein S6 and eIF4E.

47 t analysis indicated that phosphorylation of ribosomal protein S6 and extracellular-signal regulated

48 s, insulin stimulates phosphorylation of the ribosomal protein S6 and hence protein synthesis about e

49 les displayed lower levels of phosphorylated ribosomal protein S6 and higher levels of phosphorylated

50 anabolic factors acetyl-CoA carboxylase and ribosomal protein S6 and inhibiting aerobic glycolytic p

51 rylation of initiation factors 4B and 4G and ribosomal protein S6 and is due at least in part to mult

52 sis and contribute to the phosphorylation of ribosomal protein S6 and NK cell proliferation.

53 (S6K1), through phosphorylation of the 40 S ribosomal protein S6 and regulation of 5'-terminal oligo

54 ll internal antigen-1 with eIF3b, eIF4E, and ribosomal protein S6 and studied eIF2 and eIF4F complex.

55 Ang II stimulated phosphorylation of the 40S ribosomal protein S6 and the eukaryotic translation init

56 way activation as measured by phosphorylated-ribosomal protein S6 and to identify prognostic and pred

57 inversely correlates with phosphorylation of ribosomal protein S6 and tumour angiogenesis in mouse an

58 amycin pathway, decreased phosphorylation of ribosomal protein-S6 and 4E-BP1, down-regulation of cycl

59 tent phosphorylation of mTOR, p70 S6 kinase, ribosomal protein S6, and 4EB-P1; decreased cyclin D kin

60 aracteristic of ribosomal proteins including ribosomal protein S6, and a number of additional unident

61 4E (eIF4E), eIF4E-binding protein 1 (4EBP1), ribosomal protein S6, and eIF4F cap-complex formation, a

62 bundances of insulin receptor, GLUT4, AS160, ribosomal protein S6, and FOXO1.

63 ding a proline-rich Akt substrate of 40 kDa, ribosomal protein S6, and glycogen synthase kinase-3.

64 arget of rapamycin, p70 ribosomal S6 kinase, ribosomal protein S6, and mitogen activated protein kina

65 xin XI-A, the p80 subunit of the Ku antigen, ribosomal protein S6, and other unknown autoantigens cou

66 ion factor 4E-binding protein-1, p70S6K, and ribosomal protein S6, are highly phosphorylated in ALK+

67 ng MOR161-2 in vivo using the phosphorylated ribosomal protein S6 as a marker.

68 e) and S6K-RPS6 (ribosomal protein S6 kinase-ribosomal protein S6) axes.

69 ha, the catalytic activity of p70beta toward ribosomal protein S6 could be rapidly activated by serum

70 domain of pKi-67, the KIAA1671 gene product, ribosomal protein S6, cyclin K, elongation factor-2, Grb

71 Phosphorylation of ribosomal protein S6 [downstream of the mammalian target

72 that targets of the mTOR kinase, such as the ribosomal protein S6, eIF4G, and Akt, are hyperphosphory

73 mTOR pathway, as assessed by phosphorylated ribosomal protein S6 expression.

74 entally, a set of circular permutants of the ribosomal protein S6 from Thermus thermophilus was analy

75 Using conditional inactivation of the ribosomal protein S6 gene in laboratory mice, we found t

76 e two genes share a common ancestor with the ribosomal protein S6:glutamate ligase and a putative alp

77 d-alanine:d-alanine ligase and the bacterial ribosomal protein S6:glutamate ligase have been vertical

78 was associated with decreased phosphorylated ribosomal protein S6 immunoreactivity.

79 d moderate or strong hyperphosphorylation of ribosomal protein S6 in 78/107 melanomas (73%).

80 osphorylation of the mTORC1 signaling target ribosomal protein S6 in Chinese Hamster Ovary cells expr

81 IL-7 treatment increased levels of phospho-ribosomal protein S6 in HIV-specific CD8 T cells, sugges

82 stimulates the phosphorylation of STAT5 and ribosomal protein S6 in the hypothalamic arcuate nucleus

83 g behavior, and increased phosphorylation of ribosomal protein S6 in the medial prefrontal cortex (mP

84 inocyte proliferation and phosphorylation of ribosomal protein S6 in vitro.

85 protein kinase that phosphorylates the 40 S ribosomal protein S6 in vitro.

86 horylation of both S6 kinase 1 (S6K1) and S6 ribosomal protein (S6) in the LF group.

87 ger influence of pERK on pS6 (phosphorylated-ribosomal protein S6), in naive cells as compared with a

88 B (trkB), namely, phosphorylation of Akt and ribosomal protein S6, in SN neurons.

89 We report here that the mammalian 40S ribosomal protein S6 is a DAPK substrate.

90 Ribosomal protein S6 is a downstream target of the PI3K/

91 Folding of the ribosomal protein S6 is a malleable process controlled b

92 e genes Nr4a1 and Irf8 and activation of the ribosomal protein S6 is also conserved across stimuli.

93 Phosphorylation of ribosomal protein S6 is requisite for prothoracicotropic

94 The phosphorylation of ribosomal protein S6 is thought to be required for biosy

95 ing and mammalian target of rapamycin/70-kDa ribosomal protein S6 kinase (mTOR/p70S6K) were not invol

96 ade induced a prompt deactivation of the p70 ribosomal protein S6 kinase (p70 S6K).

97 se (PI3-kinase) and their downstream targets ribosomal protein S6 kinase (p70(S6k)) and eukaryotic in

98 the serine-threonine kinase Akt and the p70 ribosomal protein S6 kinase (p70(S6K)).

99 horylation state of two mTOR targets, 70-kDa ribosomal protein S6 kinase (p70S6K) and eukaryote initi

100 In the absence of ERK2, activation of the ribosomal protein S6 kinase (p70S6K) and its downstream

101 Akt/mammalian target of rapamycin (mTOR)/p70 ribosomal protein S6 kinase (p70S6K) and the extracellul

102 locking mTOR affects the activity of the 40S ribosomal protein S6 kinase (p70s6k) and the function of

103 tly attenuates phosphorylation of the 70 kDa ribosomal protein S6 kinase (p70S6K) in the basal state

104 The 70-kDa ribosomal protein S6 kinase (p70S6K) is known to regulat

105 The Akt/mammalian target of rapamycin (mTOR)/ribosomal protein S6 kinase (p70S6K) pathway is consider

106 induced IFN-y production is regulated by the ribosomal protein S6 kinase (p70S6K) through the activat

107 onds with the activation of both Akt and p70 ribosomal protein S6 kinase (p70S6K1).

108 The model suggested that ribosomal protein S6 kinase (RPS6K) plays a critical rol

109 Ribosomal protein S6 kinase (RPS6KA3 or RSK2) was the mo

110 (MAP) kinase and the Mr = 90,000 isoform of ribosomal protein S6 kinase (Rsk) by approximately 1.5-2

111 of SKAR, which is mediated by either the p90 ribosomal protein S6 kinase (RSK) or p70 S6 kinase (S6K1

112 defined positions in the active site of p90 ribosomal protein S6 kinase (RSK).

113 The 40S ribosomal protein S6 kinase (S6K) acts downstream of mTO

114 on were not affected, the phosphorylation of ribosomal protein S6 kinase (S6K) and S6 induced by mech

115 We investigated the role of ribosomal protein S6 kinase (S6K) at the intersection of

116 The 40S ribosomal protein S6 kinase (S6K) is a conserved compone

117 anslational signalling intermediates, 70 kDa ribosomal protein S6 kinase (S6k), ribosomal protein S6

118 d activity in vitro, decreased basal Akt and ribosomal protein S6 kinase (S6K1) activation, and decre

119 Here we identify ribosomal protein S6 kinase (S6K1) as a major FMRP kinas

120 70-kDa ribosomal protein S6 (rp S6) and the ribosomal protein S6 kinase (S6K1).

121 ent mammalian target of rapamycin (mTOR)/p70 ribosomal protein S6 kinase (S6K1)/eukaryotic initiation

122 eEF2 phosphorylation induced phosphorylated ribosomal protein S6 kinase (T389) up-regulation and res

123 mTORC1 also phosphorylates the 70-kDa ribosomal protein S6 kinase 1 (p70S6K1), which subsequen

124 The Ser/Thr kinase 90 kDa ribosomal protein S6 kinase 1 (p90RSK) belongs to a prot

125 de evidence that IFNlambda activates the p90 ribosomal protein S6 kinase 1 (RSK1) and its downstream

126 e, we show that multisite phosphorylation of ribosomal protein S6 kinase 1 (S6K1) alters target selec

127 l growth acting via two independent targets, ribosomal protein S6 kinase 1 (S6K1) and 4EBP1.

128 mTORC1 regulates p70 ribosomal protein S6 kinase 1 (S6K1) and eukaryotic init

129 These agonists activated ribosomal protein S6 kinase 1 (S6K1) and induced phospho

130 signaling axis and downstream effectors, the ribosomal protein S6 kinase 1 (S6K1) and the translation

131 Here we report the identification of ribosomal protein S6 kinase 1 (S6K1) as a novel substrat

132 rget of rapamycin complex 1 (mTORC1) and p70 ribosomal protein S6 kinase 1 (S6K1) axis.

133 Overexpression of Rheb activates 40S ribosomal protein S6 kinase 1 (S6K1) but not p90 ribosom

134 We found that targeting ribosomal protein S6 kinase 1 (S6K1) in Pten-deficient c

135 Suppression of the ribosomal protein S6 kinase 1 (S6K1) increases healthspa

136 Ribosomal protein S6 kinase 1 (S6K1) is a major downstre

137 p70 ribosomal protein S6 kinase 1 (S6K1) is regulated by mul

138 Leucine alone stimulated ribosomal protein s6 kinase 1 (S6K1) phosphorylation app

139 The p70 ribosomal protein S6 kinase 1 (S6K1) plays a key role in

140 tes the mammalian target of rapamycin (mTOR)/ribosomal protein S6 kinase 1 (S6K1) signaling pathway i

141 Intriguingly, the homozygous deletion of ribosomal protein S6 kinase 1 (S6K1), an mTOR target, in

142 tor 4E-binding protein (4E-BP) and activates ribosomal protein S6 kinase 1 (S6K1), both of which stim

143 Outputs downstream of mTORC1 include ribosomal protein S6 kinase 1 (S6K1), eukaryotic transla

144 metabolic pathway via its downstream target ribosomal protein S6 kinase 1 (S6K1), which directly pho

145 Overexpression of ribosomal protein S6 kinase 1 (S6k1), which encodes a do

146 cell growth and proliferation by activating ribosomal protein S6 kinase 1 (S6K1).

147 ion factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1).

148 or 4E (eIF4E) binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1).

149 ion factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1).

150 iation factor-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1).

151 ediated substrate phosphorylation (e.g., p70 ribosomal protein S6 kinase 1 [S6K1] and eukaryotic init

152 of tuberin is associated with an increase in ribosomal protein S6 kinase 1 and eukaryotic initiation

153 S6 kinase 1 inhibitor implicated a role for ribosomal protein S6 kinase 1 in IL-33-induced mTOR-depe

154 Furthermore, use of a ribosomal protein S6 kinase 1 inhibitor implicated a rol

155 ed by mTOR-Raptor and mTOR-Rictor complexes (ribosomal protein S6 kinase 1 Thr(389) and Akt Ser(473),

156 of mammalian target of rapamycin complex 1, ribosomal protein S6 kinase 1, and eukaryotic translatio

157 with phosphorylation of the mTORC1 effector ribosomal protein S6 kinase 1, that the graft morphologi

158 g non-phosphorylatable rpS6 or by inhibiting ribosomal protein S6 kinase 1-mediated rpS6 phosphorylat

159 tion of tuberin and downstream activation of ribosomal protein S6 kinase 1/4E-BP1 pathway.

160 re, we report that selectively silencing the ribosomal protein S6 kinase 2 (S6K2) while preserving th

161 In this study, we evaluated p70 ribosomal protein S6 Kinase 2 (S6K2), a downstream effec

162 Similarly, ribosomal protein S6 kinase 2 (S6K2), a recently identif

163 and CyTOF, we demonstrate that targeting of ribosomal protein S6 kinase A1 (RSK1) suppresses NFkappa

164 ma model in which constitutive activation of ribosomal protein S6 kinase A1 drives tumor invasion.

165 Transcriptomic analysis of ribosomal protein S6 kinase A1-activated tumors identifi

166 ammalian/mechanistic target of rapamycin and ribosomal protein S6 kinase A1.

167 inhibition resulted in TLR-4-mediated 70-kDa ribosomal protein S6 kinase activation and enhanced TNF-

168 in vivo, of the eEF2k/eEF2 pathway impact on ribosomal protein S6 kinase activity as well as protein

169 p70 ribosomal protein S6 kinase activity was induced by K-Ra

170 am target of the cyclooxygenase pathway, and ribosomal protein S6 kinase and eukaryotic translation i

171 nd p38 MAPK and suggested involvement of p90 ribosomal protein S6 kinase and mitogen and stress respo

172 ivated protein kinase (AMPK) and upstream of ribosomal protein S6 kinase and mTOR complex 1 (TORC1),

173 Furthermore, ribosomal protein S6 kinase and S6 phosphorylation were

174 hey show constitutive phosphorylation of the ribosomal protein S6 kinase and the eukaryotic initiatio

175 appear to involve the phosphorylation of the ribosomal protein S6 kinase at Thr389 and of insulin rec

176 We investigated regulation of ribosomal protein S6 kinase B1 (RPS6KB1) by AURKA and th

177 ubstrates such as protein kinase B (AKT) and ribosomal protein S6 kinase beta (S6K) have been well es

178 Here we report that ribosomal protein S6 kinase beta 1 (S6K1), a member of A

179 The human kinase ribosomal protein S6 kinase beta-1 (RPS6KB1) was shown t

180 age proinflammatory activation by catalyzing ribosomal protein S6 kinase beta-1 (S6K1) O-GlcNAcylatio

181 of mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase beta-1 (S6K1) pathway in car

182 ene ESR1, and another involving the RPS6KB1 (Ribosomal protein S6 kinase beta-1) were recurrently exp

183 The ribosomal protein S6 kinase family members play essentia

184 p70 Ribosomal protein S6 kinase is a critical down-stream ef

185 The 70/85 kDa ribosomal protein S6 kinase is regulated through the con

186 ein kinase B on Ser(473), mTOR on Ser(2448), ribosomal protein S6 kinase on Thr(389), and eukaryotic

187 ied, phosphoinositide 3-kinase p110alpha and ribosomal protein S6 kinase p70(S6K1), plus the MAP kina

188 lian target of rapamycin complex-1 (mTORC-1)/ribosomal protein S6 kinase pathways.

189 gnaling in the tumor, as measured by reduced ribosomal protein S6 kinase phosphorylation.

190 mitogen-activated protein kinase 2 (ERK) and ribosomal protein S6 kinase polypeptide 2 (p90RSK).

191 urse experiment indicated that PI3K (AKT and ribosomal protein S6 kinase) activation occurred between

192 ponents of the mammalian target of rapamycin/ribosomal protein S6 kinase, 70 kDa, pathway and thereby

193 the oncogenic mammalian target of rapamycin/ribosomal protein S6 kinase, 70 kDa, pathway, and the im

194 Ribosomal protein S6 kinase, 90 kDa, polypeptide 1 (RSK1

195 lving extracellular signal-regulated kinase, ribosomal protein S6 kinase, and protein kinase D (PKD)

196 ith and inhibited B-Raf but did not activate ribosomal protein S6 kinase, indicating that farnesylati

197 ucine also stimulated phosphorylation of the ribosomal protein S6 kinase, p70(S6k), resulting in incr

198 mycin (i.e., phosphorylation of AMPK and p70 ribosomal protein S6 kinase, respectively) and IL-6/IL-6

199 D relative to control subjects was found for ribosomal protein S6 kinase, which did not change after

200 eroxide each caused inhibition of the 70-kDa ribosomal protein S6 kinase, while arsenite activated it

201 ctivated phospho-ERK44/42, activated phospho-ribosomal protein S6 kinase-1 (RSK1) (a substrate of ERK

202 ) mice, we found that targeting the mTOR and ribosomal protein S6 kinase-1 (S6K1) signaling pathways

203 ion factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase-1 (S6K1), whereas HIF-1alpha

204 e here that Rictor is a direct target of the ribosomal protein S6 kinase-1 (S6K1).

205 vation of its downstream targets Akt and the ribosomal protein S6 kinase-1 (S6K1).

206 the T-loop of S6K1 alpha II (the 70-kDa 40 S ribosomal protein S6 kinase-1 alpha II isoform), and Thr

207 lular signal-regulated kinase) and S6K-RPS6 (ribosomal protein S6 kinase-ribosomal protein S6) axes.

208 protein, 4E-BP1, and the activity of the p70 ribosomal protein S6 kinase.

209 tein kinase pathway, involving in particular ribosomal protein S6 kinase.

210 Little is known about ribosomal proteins S6 kinase C1 (RPS6KC1), aside from it

211 ignaling alteration, indicative of increased ribosomal protein S6-kinase activity.

212 /42 mitogen activated protein kinases (MAPK)/ribosomal protein S6 kinases (p70 S6K) pathway.

213 as in activation and phosphorylation of p90 ribosomal protein S6 kinases (RSKs).

214 st known to regulate translation through the ribosomal protein S6 kinases (S6Ks) and the eukaryotic t

215 In mammalian cells, the ribosomal protein S6 kinases, S6K1 and S6K2, lie downstr

216 leading to the stimulation of the 70/85 kDa ribosomal protein S6 kinases, substantially blocks the a

217 AKT serine/threonine-protein-kinase (AKT3), ribosomal-protein-S6, MAP-kinases, and NF-kappaB-activat

218 SH-mediated activation of the mTOR complex 1/ribosomal protein S6 (mTORC1/RPS6) pathway as well as th

219 it independently impaired phosphorylation of ribosomal protein S6 on the preinitiation complex.

220 overexpression increased phosphorylation of ribosomal protein S6 (p-rpS6) in SNpc neurons, a readout

221 sphate feeding, generate less phosphorylated ribosomal protein S6 (P-S6) than the WT.

222 Here, the signal from phosphorylated ribosomal protein S6 (P-S6) was defined as a surrogate m

223 educed constitutive activation of the mTORC1/ribosomal protein S6 pathway and downregulated constitut

224 wed no measurable kinase activity toward the ribosomal protein S6 peptide.

225 Thus, HU-308 increased ribosomal protein S6 phosphorylation and 5-bromo-2'-deox

226 min following exercise (336%, P = 0.06) with ribosomal protein S6 phosphorylation being maximally act

227 In contrast, suppression of S6K1 and ribosomal protein S6 phosphorylation by DNA damage is Ak

228 n of cAMP-dependent protein kinase, to drive ribosomal protein S6 phosphorylation.

229 t not related monomeric G proteins, promotes ribosomal protein S6 phosphorylation.

230 ing, and caused decreases in Akt Ser-473 and ribosomal protein S6 phosphorylation.

231 mechanism that can function independently of ribosomal protein S6 phosphorylation.

232 uppression of proliferation marker Ki-67 and ribosomal protein S6 phosphorylation.

233 Immunohistochemistry showed patches of ribosomal protein S6 positivity in a similar distributio

234 of this study was to examine the role of the ribosomal protein S6 protein kinase (p70S6K), a protein

235 tified activity-dependent phosphorylation of ribosomal protein S6 (pS6) across the dorsal hippocampus

236 fasting plasma C-peptide, and phosphorylated ribosomal protein S6 (pS6) in skin biopsies.

237 phorylated (p)-4E-BP1, p-p70S6 kinase, and p-ribosomal protein S6, resulting in apoptosis and cell cy

238 increased the phosphorylation of the 70-kDa ribosomal protein S6 (rp S6) and the ribosomal protein S

239 nduce an up-regulation of phosphorylated (p)-ribosomal protein S6 (rpS6) (namely, p-rpS6-S235/S236) a

240 mTORC1 functions by regulating p70S6K/ribosomal protein S6 (RPS6) and eukaryotic translation i

241 e demonstrate here that nsP2 associates with ribosomal protein S6 (RpS6) and that nsP2 is present in

242 Functionally, the phosphorylation of ribosomal protein S6 (rpS6) and the amount of phosphoryl

243 evealed increased phosphorylation of the 40S ribosomal protein S6 (rpS6) and the eukaryotic translati

244 rs prolonged signaling through activation of ribosomal protein S6 (RPS6) and the upstream kinase 90-k

245 ockout endothelial cells, phosphorylation of ribosomal protein S6 (rpS6) at Ser235/236 was mostly abr

246 We observed ribosomal protein S6 (RPS6) hyperphosphorylation as a sh

247 1 (4E-BP1) and increased phosphorylation of ribosomal protein S6 (rpS6) in activated renal tubules.

248 tion domain-containing protein 1 (RCCD1) and ribosomal protein S6 (RPS6) in vitro.

249 Here, we show that ribosomal protein S6 (RPS6) interacts with LANA.

250 Ribosomal protein S6 (rpS6) is a critical component of t

251 Ribosomal protein S6 (rpS6) is an essential component of

252 In this study, we demonstrate that ribosomal protein S6 (RPS6) is highly expressed in prima

253 Ribosomal protein S6 (RPS6) is located in the mRNA bindi

254 The ribosomal protein S6 (RPS6) is one of the well known dow

255 Ribosomal protein S6 (rpS6) is phosphorylated in vivo by

256 Gain- and loss-of-function Ribosomal Protein S6 (RPS6) mutants additionally show th

257 hypochromic skin patches, we identified the ribosomal protein S6 (RPS6) p.R232H variant, present as

258 bservations showed a paradoxical increase in ribosomal protein S6 (rpS6) phosphorylation and a decrea

259 Ribosomal protein S6 (rpS6) phosphorylation mediates the

260 x protein PALL interacts with phosphorylated ribosomal protein S6 (RpS6) to promote its ubiquitylatio

261 was measured by increased phosphorylation of ribosomal protein S6 (rpS6), a downstream target of the

262 Here, we focus on ribosomal protein S6 (rpS6), an mTOR effector not implic

263 s, 70 kDa ribosomal protein S6 kinase (S6k), ribosomal protein S6 (rpS6), eukaryotic elongation facto

264 r was associated with the phosphorylation of ribosomal protein S6 (rpS6), suggesting activation of th

265 ibosomal subunit contains the key regulatory ribosomal protein S6 (rpS6), we considered that myc loss

266 initiation proteins, eIF3A, eIF4G, and small ribosomal protein S6 (rpS6), were redistributed into foc

267 lates positively with that of phosphorylated ribosomal protein S6 (RPS6).

268 ox O3 (FOXO3) and reduced phosphorylation of ribosomal protein S6 (RPS6).

269 or eIF4E-binding protein 1 (4E-BP1), but not ribosomal protein S6 (rpS6).

270 lls derived from the hematopoietic organs of ribosomal protein S6 (RpS6air8) mutant animals express h

271 ns involved in translational control, namely ribosomal protein S6 (rS6) and 4E-BP1.

272 Moreover, we demonstrate that ribosomal protein S6 (rS6) and Akt, downstream targets o

273 ition of the latter process by knockdowns of ribosomal proteins S6, S14, or L4 reduced ribosome conte

274 presses the phosphorylation of GSK3betaser9, ribosomal protein S6(S240/244), and AKT(Thr308).

275 on protein (Arc), CaMKII and phospho-CaMKII, ribosomal protein S6 (S6) and phospho-S6, and calcineuri

276 factor 4E binding protein 1 (4E-BP1) and the ribosomal protein S6 (S6), increased in comparison with

277 at dasatinib reduced p70 S6 kinase (S6K) and ribosomal protein S6 (S6), leading to substantial reduct

278 We found that ribosomal protein S6 (S6), which exerts translational co

279 he effects of aspirin on mTOR signaling, the ribosomal protein S6, S6 kinase 1 (S6K1), and eukaryotic

280 6 kinase (p70S6K) and its downstream target, ribosomal protein S6 (S6RP), was impaired at a critical

281 platform of the 30 S subunit upon binding of ribosomal proteins S6, S8, S11, S15, S18 and S21.

282 binding protein 1 (Thr-37/46 and Thr-70) and ribosomal protein S6 (Ser-235/236) and increased the pho

283 sphorylation of p70 S6 kinase (Thr-389), and ribosomal protein S6 (Ser-235/236) in Rh1, Rh18, and Rh3

284 ted protein kinase (AMPK) alpha (Thr172) and ribosomal protein S6 (Ser235/Ser236) was performed using

285 1(Thr412) , 19%; p70 S6K1(Thr389) , 58%) and ribosomal protein S6(Ser235/236) (37%), greater rested-s

286 es expressed higher levels of phosphorylated ribosomal protein S6 than paired fibroblasts from normal

287 -E1A12 increased phosphorylation of AKT1 and ribosomal protein S6 through independent mechanisms in d

288 Phosphorylation of ribosomal protein S6, typically a downstream target of m

289 ion and the transition state ensemble of the ribosomal protein S6 using a Monte Carlo (MC) Go model i

290 Phosphorylation of ribosomal protein S6 was also modulated by inhibition of

291 ls, and decreased phosphorylation of phospho-ribosomal protein S6 was also observed, a finding sugges

292 y, activation of S6 Kinase and its target S6 ribosomal protein (S6) was demonstrated in cells lacking

293 stress-activated protein kinase 1 and rpS6 (ribosomal protein S6) was largely unchanged under these

294 horylation of a downstream target of mTORC1, ribosomal protein S6, was inhibited by EAD1.

295 nd phosphorylation levels of Akt, FoxO3, and ribosomal protein S6 were determined by Western blotting

296 oposed to be regulated by phosphorylation of ribosomal protein S6, which is a common effect of mitoge